MXPA02011939A - Composiciones con bajo contenido de carbohidratos paquetes combinados que las contienen y metodos de uso. - Google Patents

Composiciones con bajo contenido de carbohidratos paquetes combinados que las contienen y metodos de uso.

Info

Publication number
MXPA02011939A
MXPA02011939A MXPA02011939A MXPA02011939A MXPA02011939A MX PA02011939 A MXPA02011939 A MX PA02011939A MX PA02011939 A MXPA02011939 A MX PA02011939A MX PA02011939 A MXPA02011939 A MX PA02011939A MX PA02011939 A MXPA02011939 A MX PA02011939A
Authority
MX
Mexico
Prior art keywords
methylsulfonylmethane
compositions
present
chondroprotective
aminosugars
Prior art date
Application number
MXPA02011939A
Other languages
English (en)
Inventor
Matthew Thomas Heisey
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/759,965 external-priority patent/US20020132780A1/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MXPA02011939A publication Critical patent/MXPA02011939A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion se relaciona a composiciones, paquetes combinados y metodos utilizados para el tratamiento de la disfuncion de las articulaciones, disfuncion de los huesos y/o inflamacion. La composicion utilizada en la presente es util para aquellos mamiferos que experimentan dolor, debilidad e inflamacion en articulaciones, sobre todo en huesos, y es particularmente adecuada para mamiferos que son diabeticos o en riesgo de tener diabetes, asi como para aquellos que desean o requieren de composiciones condroprotectoras convenientemente dosificadas que tengan un bajo contenido de carbohidratos, un bajo valor calorico y/o que tengan un bajo indice glusemico. En particular, las presentes composiciones comprende: a) un agente condroprotector seleccionado a partir de la gelatina, cartilago, aminoazucares, glucosaminoglucanos, metilsulfonilmetano, precursores del metilsulfonilmetano, S-adenosilmetionina y mezclas de estos; b) un agente endulzante diferente a la glucosa, dextrosa, sacarosa y fructosa; y c) por lo menos aproximadamente un 10% de agua, por peso de la composicion. En una modalidad alternativa de la presente invencion, las presentes composiciones comprenden: a) un agente condroprotector seleccionado a partir de la gelatina, cartilago, aminoazucares, glucosaminoglucanos, metilsulfonilmetano, precursores del metilsulfonilmetano, S-adenosilmetionina, sales de estos y mezclas de estos; y b) un agente endulzante diferente a la glucosa, dextrosa, sacarosa y fructosa; en donde la composicion se encuentra sustancialmente libre de aspartame. Otras composiciones de la presente invencion comprenden un agente condroprotector seleccionado a partir de la gelatina, cartilago, aminoazucares, glucosaminoglucanos, metilsulfonilmetano, precursores del metilsulfonilmetano, S-adenosilmetionina y mezclas de estos, y tienen un bajo contenido de carbohidratos como se define en la presente.
MXPA02011939A 2000-06-02 2001-06-01 Composiciones con bajo contenido de carbohidratos paquetes combinados que las contienen y metodos de uso. MXPA02011939A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58651400A 2000-06-02 2000-06-02
US09/759,965 US20020132780A1 (en) 2001-01-12 2001-01-12 Low carbohydrate compositions, kits thereof, and methods of use
PCT/US2001/017716 WO2001093831A2 (en) 2000-06-02 2001-06-01 Low carbohydrate compositions, kits thereof, and methods of use

Publications (1)

Publication Number Publication Date
MXPA02011939A true MXPA02011939A (es) 2003-04-22

Family

ID=27079730

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011939A MXPA02011939A (es) 2000-06-02 2001-06-01 Composiciones con bajo contenido de carbohidratos paquetes combinados que las contienen y metodos de uso.

Country Status (8)

Country Link
EP (1) EP1289532A2 (es)
JP (1) JP2003535120A (es)
CN (1) CN1438892A (es)
AU (1) AU2001269730A1 (es)
BR (1) BR0111292A (es)
CA (1) CA2408610A1 (es)
MX (1) MXPA02011939A (es)
WO (1) WO2001093831A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431937B2 (en) * 2001-03-30 2008-10-07 L'oreal, S.A. Compositions comprising at least one aminated C5-C7 saccharide unit, and their use for the protection and/or repair of keratinous fibers
US20040052915A1 (en) 2002-09-13 2004-03-18 Carlson Ting L. Use of low glycemic index sweeteners in food and beverage compositions
AU2003903037A0 (en) 2003-06-17 2003-07-03 Institute Of Nutraceutical Research Connective tissue derived polypeptides
ES2611887T3 (es) * 2005-11-23 2017-05-11 The Coca-Cola Company Composiciones de edulcorante de alta potencia natural con perfil temporal y/o perfil de aroma mejorados
CN102307578B (zh) * 2008-03-11 2016-05-04 利维昂尼克斯公司 治疗炎症和炎症相关疾病的方法和组合物
KR101314322B1 (ko) * 2009-09-28 2013-10-02 박유신 관절 및 결체조직 관련 질병의 치료 및 예방을 위한 약학 조성물
EP2983783B1 (en) 2013-03-15 2021-04-21 New York University Citrate containing beverage
CN106714810A (zh) * 2014-04-14 2017-05-24 甲基化物科学国际有限公司 新型腺苷甲硫氨酸制剂
JP6528588B2 (ja) * 2014-08-19 2019-06-12 大正製薬株式会社 固形製剤
KR101957502B1 (ko) * 2018-08-17 2019-03-12 이승훈 메틸설포닐메탄을 함유하는 비만, 지방간 및 당뇨병 예방 또는 개선용 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2103387C3 (de) * 1971-01-26 1982-05-06 Johann G.W. Opfermann & Sohn, 5070 Bergisch-Gladbach Verwendung des Hydrochlorids von Glukosamin zur Herstellung von pharmazeutischen Präparaten
JP3693359B2 (ja) * 1993-07-21 2005-09-07 マルハ株式会社 骨強化促進剤
IT1270095B (it) * 1994-09-28 1997-04-28 Ibsa Inst Biochimique Sa Composizioni terapeutiche di condroitin solfato sotto forma di gel somministrabile per via orale
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
JP4070844B2 (ja) * 1997-08-20 2008-04-02 株式会社ヤクルト本社 マグネシウム含有経口組成物
JP2971855B1 (ja) * 1998-06-22 1999-11-08 明治乳業株式会社 風味のよいアミノ酸含有食品の製造方法
US6391864B1 (en) * 1998-08-19 2002-05-21 Joint Juice, Inc. Food supplement containing a cartilage supplement
DE19838794A1 (de) * 1998-08-26 2000-03-09 Aristavet Veterinaerspezialita Zusammensetzung zur Behandlung von Osteoarthritis und zur nutritiven Behandlung des Gelenkknorpels
JP4300652B2 (ja) * 1998-09-21 2009-07-22 大正製薬株式会社 経口用固形製剤
US5993880A (en) * 1998-10-01 1999-11-30 Kraft Foods Inc. Non-staining, acid-stable, cold-water-soluble, edible green color and compositions for preparing acidic foods and beverages
JP2000175648A (ja) * 1998-12-11 2000-06-27 Sanei Gen Ffi Inc 乳清ミネラルを含有する甘味組成物
ZA9811635B (en) * 1998-12-18 1999-07-28 Gerard Finn Glucosamine hydrochloride drink
DE19859771C1 (de) * 1998-12-23 2000-08-24 Sueddeutsche Kalkstickstoff Wasserlösliche, stabile Brenztraubensäure(-salze)-enthaltende Formulierung
JP2000281562A (ja) * 1999-03-30 2000-10-10 Taisho Pharmaceut Co Ltd ゲル状組成物
JP2000290199A (ja) * 1999-03-31 2000-10-17 Taisho Pharmaceut Co Ltd 経口用医薬組成物
JP4173606B2 (ja) * 1999-06-18 2008-10-29 サントリー株式会社 低酸性飲料の製造方法

Also Published As

Publication number Publication date
WO2001093831A3 (en) 2002-04-25
CN1438892A (zh) 2003-08-27
BR0111292A (pt) 2003-06-10
CA2408610A1 (en) 2001-12-13
AU2001269730A1 (en) 2001-12-17
WO2001093831A2 (en) 2001-12-13
EP1289532A2 (en) 2003-03-12
JP2003535120A (ja) 2003-11-25

Similar Documents

Publication Publication Date Title
MXPA02011939A (es) Composiciones con bajo contenido de carbohidratos paquetes combinados que las contienen y metodos de uso.
BRPI0620042B8 (pt) composição de carboidrato de baixo teor glicêmico disponível, composição nutricional líquida, e, uso de uma composição de carboidrato
BRPI0503981A (pt) substituto do açúcar apetecìvel, de baixa caloria com agente de volume insolúvel em água
KR960036932A (ko) 트레할로오스 고함유 시럽
PT93847A (pt) Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
DK1369432T3 (da) Meget forgrenede oplöselige glucosepolymerer og fremgangsmåde til fremstilling deraf
US5869461A (en) Reducing toxicity of L-nucleosides with D-nucleosides
EA200001191A1 (ru) Новые фармацевтические композиции для лечения и жизнеобеспечения (поддержания жизненных функций) и способ их приготовления
TR199802394A2 (xx) Proteinleri stabilize etmek i�in geli�tirilmi� proses.
TW580391B (en) Sulfated oligosaccharides having anticoagulant/antithrombotic activity
KR940003547A (ko) 제산제
ES2055270T3 (es) Uso de l-azucares para la fabricacion de composiciones laxantes.
ES2095658T3 (es) Composicion para la liberacion controlada de una substancia activa y metodo para la preparacion de tal composicion.
BR0309057A (pt) Formulações lìquidas com baixa dosagem em entecavir e uso
KR950008528A (ko) 두개의 당류와 하나의 스페이서(spacer)를 함유하는 이결합체
BG105795A (en) Derivatives of monosaccharides as cell adhesion inhibitors
PT1213972E (pt) Composicao compreendendo um inibidor da alfa-amilase e pelo menos um composto fisiologicamente aceitavel capaz de reduzir a absorcao intestinal dos "acucares rapidos"
KR950703977A (ko) 글루코오스 에스테르 유도체를 함유한 뇌대사 개선제(cerebral metabolism activator containing glucose ester derivative)
AR016259A1 (es) Composicion edulcorante y sus usos
KR970032871A (ko) 피부염의 치료외용제
BR9915609A (pt) Método para reduzir descoloração de estanho em composições dentifrìcias
BR9915284A (pt) Método de tratamento
EP2090314A1 (en) Ophthalmic aqeous liquid preparation
Ozawa et al. Suppression of mitochondrial response to hepatectomy in diabetic rats
BR0010283A (pt) Novos inibidores especìficos de inflamação aguda e crÈnica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal